Abstract
Fibrillar protein aggregates are the major pathological hallmark of several incurable, age-related, neurodegenerative disorders. These aggregates typically contain aggregation-prone pathogenic proteins, such as amyloid-beta in Alzheimer's disease and alpha-synuclein in Parkinson's disease. It is, however, poorly understood how these aggregates are formed during cellular aging. Here we identify an evolutionarily highly conserved modifier of aggregation, MOAG-4, as a positive regulator of aggregate formation in C. elegans models for polyglutamine diseases. Inactivation of MOAG-4 suppresses the formation of compact polyglutamine aggregation intermediates that are required for aggregate formation. The role of MOAG-4 in driving aggregation extends to amyloid-beta and alpha-synuclein and is evolutionarily conserved in its human orthologs SERF1A and SERF2. MOAG-4/SERF appears to act independently from HSF-1-induced molecular chaperones, proteasomal degradation, and autophagy. Our results suggest that MOAG-4/SERF regulates age-related proteotoxicity through a previously unexplored pathway, which will open up new avenues for research on age-related, neurodegenerative diseases.
Original language | English |
---|---|
Pages (from-to) | 601-612 |
Number of pages | 12 |
Journal | Cell |
Volume | 142 |
Issue number | 4 |
DOIs | |
Publication status | Published - 20-Aug-2010 |
Keywords
- INCLUSION-BODY FORMATION
- HEAT-SHOCK FACTOR
- CAENORHABDITIS-ELEGANS
- HUNTINGTONS-DISEASE
- POLYGLUTAMINE EXPANSIONS
- MOLECULAR CHAPERONES
- PROTEIN-DEGRADATION
- CELLULAR TOXICITY
- MUTANT HUNTINGTIN
- QUALITY-CONTROL